Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 6 | 2025 | 459 | 2.020 |
Why?
|
| Placenta | 3 | 2025 | 511 | 1.560 |
Why?
|
| Elasticity Imaging Techniques | 5 | 2021 | 144 | 1.300 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2025 | 3695 | 1.290 |
Why?
|
| Skull | 2 | 2018 | 147 | 0.980 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 27 | 0.880 |
Why?
|
| Placenta Accreta | 1 | 2025 | 163 | 0.750 |
Why?
|
| Hepatoblastoma | 4 | 2025 | 186 | 0.680 |
Why?
|
| Amyloid | 1 | 2020 | 69 | 0.640 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 72 | 0.640 |
Why?
|
| Movement | 2 | 2018 | 143 | 0.640 |
Why?
|
| Brain | 6 | 2024 | 3038 | 0.640 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 835 | 0.630 |
Why?
|
| Scalp | 1 | 2018 | 57 | 0.540 |
Why?
|
| Liver Neoplasms | 4 | 2025 | 1351 | 0.390 |
Why?
|
| Mice | 10 | 2025 | 17596 | 0.310 |
Why?
|
| Gadolinium | 2 | 2019 | 110 | 0.290 |
Why?
|
| Biomechanical Phenomena | 3 | 2018 | 254 | 0.290 |
Why?
|
| Liposomes | 2 | 2019 | 196 | 0.290 |
Why?
|
| Animals | 14 | 2025 | 33051 | 0.270 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.240 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2025 | 41 | 0.230 |
Why?
|
| Pregnancy | 3 | 2025 | 7373 | 0.220 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 76 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 93 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 774 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.170 |
Why?
|
| Presenilin-1 | 1 | 2020 | 57 | 0.170 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 81 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 144 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 4504 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2020 | 362 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 285 | 0.160 |
Why?
|
| Phantoms, Imaging | 2 | 2018 | 128 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2022 | 351 | 0.160 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 130 | 0.160 |
Why?
|
| Blood Volume | 1 | 2019 | 71 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 255 | 0.150 |
Why?
|
| Fluorine | 1 | 2018 | 14 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2310 | 0.150 |
Why?
|
| Placentation | 1 | 2019 | 58 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 386 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 61 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 14 | 0.140 |
Why?
|
| Swine | 2 | 2018 | 1171 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 579 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1595 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2022 | 539 | 0.130 |
Why?
|
| Models, Animal | 1 | 2019 | 452 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2019 | 267 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3709 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 677 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2020 | 756 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 4429 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 726 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3498 | 0.120 |
Why?
|
| White Matter | 1 | 2017 | 205 | 0.110 |
Why?
|
| Female | 5 | 2025 | 68330 | 0.110 |
Why?
|
| Humans | 11 | 2025 | 126753 | 0.110 |
Why?
|
| Gestational Age | 1 | 2019 | 1186 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 3390 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 588 | 0.110 |
Why?
|
| Vincristine | 2 | 2025 | 190 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2022 | 929 | 0.110 |
Why?
|
| Adult | 2 | 2025 | 30410 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 946 | 0.080 |
Why?
|
| Apoptosis | 2 | 2025 | 1811 | 0.060 |
Why?
|
| Indolizines | 1 | 2025 | 8 | 0.060 |
Why?
|
| Cyclic N-Oxides | 1 | 2025 | 17 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2025 | 33 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2018 | 358 | 0.060 |
Why?
|
| Male | 3 | 2021 | 62543 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 57 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 79 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 841 | 0.050 |
Why?
|
| Indocyanine Green | 1 | 2023 | 53 | 0.050 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 56 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 63 | 0.050 |
Why?
|
| Adventitia | 1 | 2022 | 5 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 291 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 153 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 245 | 0.040 |
Why?
|
| Elasticity | 1 | 2021 | 93 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 236 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 372 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 38 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 59 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 74 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 120 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2397 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 824 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 53 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 665 | 0.030 |
Why?
|
| Anisotropy | 1 | 2017 | 116 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1234 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2039 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1931 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1765 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3222 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4954 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4472 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20344 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 14347 | 0.010 |
Why?
|